121 related articles for article (PubMed ID: 37968147)
1. ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
Tran A; Weigel RJ; Beck AC
Am J Surg; 2024 Mar; 229():106-110. PubMed ID: 37968147
[TBL] [Abstract][Full Text] [Related]
2. Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
[TBL] [Abstract][Full Text] [Related]
3. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.
Ahn D; Sohn JH; Jeon JH; Jeong JY
J Endocrinol Invest; 2014 Feb; 37(2):167-73. PubMed ID: 24497215
[TBL] [Abstract][Full Text] [Related]
5. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.
Pitoia F; Jerkovich F; Urciuoli C; Schmidt A; Abelleira E; Bueno F; Cross G; Tuttle RM
Thyroid; 2015 Nov; 25(11):1235-42. PubMed ID: 26132983
[TBL] [Abstract][Full Text] [Related]
6. Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
Back K; Lee J; Choe JH; Kim JH; Oh YL; Kim JS
Am J Surg; 2022 Apr; 223(4):635-640. PubMed ID: 34446213
[TBL] [Abstract][Full Text] [Related]
7. Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Song E; Ahn J; Song DE; Kim WW; Jeon MJ; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
Clin Endocrinol (Oxf); 2020 Apr; 92(4):358-365. PubMed ID: 31630423
[TBL] [Abstract][Full Text] [Related]
8. Conservative thyroidectomy for papillary thyroid microcarcinoma.
Nahm HJ; Choi SJ; Lim YC
Am J Otolaryngol; 2019; 40(3):427-430. PubMed ID: 30928297
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
11. Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system.
Markantes GK; Karakioulaki M; Papanikolopoulou S; Theodoropoulou A; Markou KB; Vagenakis AG; Spyridonidis T; Goulis DG; Michalaki MA
Hormones (Athens); 2021 Dec; 20(4):761-768. PubMed ID: 34383288
[TBL] [Abstract][Full Text] [Related]
12. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
Song RY; Kim HS; Kang KH
World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonographic features associated with false-negative and false-positive results of extrathyroidal extensions in papillary thyroid microcarcinoma.
Lee YC; Jung AR; Sohn YM; Kim EJ; Eun YG
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2817-2822. PubMed ID: 30178419
[TBL] [Abstract][Full Text] [Related]
14. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
[TBL] [Abstract][Full Text] [Related]
15. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy.
Jeon YW; Gwak HG; Lim ST; Schneider J; Suh YJ
Ann Surg Oncol; 2019 Sep; 26(9):2952-2958. PubMed ID: 31264119
[TBL] [Abstract][Full Text] [Related]
17. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
18. Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.
Pérez-Soto RH; Velázquez-Fernández D; Arellano-Gutiérrez G; Chapa-Ibargüengoitia M; Trolle-Silva AM; Iñiguez-Ariza N; Pérez-Enríquez B; Sierra-Salazar M; Pantoja Millán JP; Herrera MF
Thyroid; 2020 Jun; 30(6):857-862. PubMed ID: 32031061
[No Abstract] [Full Text] [Related]
19. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid microcarcinoma: characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort.
Domínguez JM; Nilo F; Martínez MT; Massardo JM; Muñoz S; Contreras T; Carmona R; Jerez J; González H; Droppelmann N; León A
Arch Endocrinol Metab; 2018 Feb; 62(1):6-13. PubMed ID: 29694628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]